 |
 |
| The 75-strong Ra Medical Systems workforce, seen here at the company's Carlsbad, California, headquarters. If the planned IPO is a success, there should be a major expansion of sales and marketing efforts and support for further clinical trials of the firm's excimer laser treatment for peripheral artery disease - blocked arteries in the limbs that lead to heart attacks, strokes, and amputations. Image: Ra Medical Systems via Twitter. |
| © 2024 SPIE Europe |
|
